Innovation Pharmaceuticals Stock Short Ratio
| IPIX Stock | USD 0.0003 0.0002 200.00% |
Innovation Pharmaceuticals fundamentals help investors to digest information that contributes to Innovation Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Innovation Pink Sheet. The fundamental analysis module provides a way to measure Innovation Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Innovation Pharmaceuticals pink sheet.
Innovation |
Innovation Pharmaceuticals Company Short Ratio Analysis
Innovation Pharmaceuticals' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Innovation Pharmaceuticals has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Innovation Fundamentals
| Return On Equity | -1.09 | |||
| Return On Asset | -0.32 | |||
| Operating Margin | (339.83) % | |||
| Current Valuation | 7.56 M | |||
| Shares Outstanding | 488.32 M | |||
| Shares Owned By Insiders | 10.10 % | |||
| Price To Earning | (7.57) X | |||
| Price To Book | 2.95 X | |||
| Price To Sales | 557.16 X | |||
| Revenue | 18 K | |||
| Gross Profit | 18 K | |||
| EBITDA | (6.54 M) | |||
| Net Income | (7.04 M) | |||
| Cash And Equivalents | 2.97 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 1.24 M | |||
| Debt To Equity | 0.36 % | |||
| Current Ratio | 0.60 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (6.28 M) | |||
| Earnings Per Share | (0.02) X | |||
| Beta | 0.18 | |||
| Market Capitalization | 9.52 M | |||
| Total Asset | 10.38 M | |||
| Retained Earnings | (87.38 M) | |||
| Working Capital | 44.72 K | |||
| Current Asset | 529.15 K | |||
| Current Liabilities | 484.43 K | |||
| Z Score | -7.0 | |||
| Net Asset | 10.38 M |
About Innovation Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Innovation Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Innovation Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Innovation Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Innovation Pink Sheet Analysis
When running Innovation Pharmaceuticals' price analysis, check to measure Innovation Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation Pharmaceuticals is operating at the current time. Most of Innovation Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Innovation Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation Pharmaceuticals' price. Additionally, you may evaluate how the addition of Innovation Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.